Illumina Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AVGO | Broadcom | Outperform |
8
|
$1.28k | $1.21k | 21.66% | 11 | $592.30B |
| MRK | Merck | Outperform |
2
|
$127.51 | $130.51 | 12.15% | 11 | $322.96B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.50 | £165.99 | 35.23% | 16 | £186.80B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$572.38 | $591.94 | 8.32% | 1 | $218.49B |
| NOVN | Novartis | Hold |
10
|
CHF87.97 | CHF105.00 | 22.34% | 9 | CHF179.49B |
| ROG | Roche Holding | Hold |
16
|
CHF217.30 | CHF307.83 | 25.40% | 9 | CHF175.19B |
| ABT | Abbott Laboratories | Outperform |
9
|
$105.90 | $118.92 | 18.04% | 7 | $184.23B |
| DHR | Danaher | Outperform |
10
|
$248.38 | $260.33 | 9.68% | 4 | $183.97B |
| AMGN | Amgen | Outperform |
4
|
$311.29 | $303.65 | 2.80% | 8 | $166.99B |
| PFE | Pfizer | Outperform |
2
|
$27.81 | $32.87 | 9.67% | 6 | $157.48B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.99 | $58.15 | 22.76% | 10 | $89.17B |
| GSK | GSK | Outperform |
12
|
£17.34 | £17.30 | 12.46% | 12 | £70.69B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$64.78 | $87.82 | 23.49% | 14 | $80.78B |
| LONN | Lonza Group | Buy |
16
|
CHF519.60 | CHF516.89 | 14.51% | 8 | CHF37.47B |
| A | Agilent Technologies | Outperform |
10
|
$139.45 | $138.82 | 8.28% | 10 | $40.87B |
| DSFIR | DSM-Firmenich | Outperform |
18
|
104.60€ | 114.60€ | 14.72% | 0 | 27.75€B |
| LH | Laboratory Corp of America Hol... | Outperform |
11
|
$201.32 | $241.28 | 20.21% | 9 | $16.97B |
| SY1 | Symrise | Outperform |
18
|
100.75€ | 106.97€ | 11.17% | 5 | 14.08€B |
| BIM | bioMérieux | Outperform |
18
|
98.70€ | 105.55€ | 15.50% | 1 | 11.82€B |
| 500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp6.35k | Rp5.67k | -4.72% | 25 | Rp1.03T |
| TECH | Bio-Techne Corp | Buy |
16
|
$77.29 | $100.78 | 8.68% | 2 | $12.15B |
| NTRA | Natera | Buy |
7
|
$96.98 | $74.41 | 6.72% | 8 | $11.35B |
| 6869 | Sysmex | Outperform |
18
|
¥7.99k | ¥8.90k | 11.40% | 0 | ¥1.74T |
| EXAS | Exact Sciences | Buy |
8
|
$62.07 | $90.32 | 43.72% | 7 | $10.91B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$42.98 | $0.00 | 16.33% | 3 | $9.39B |
| CRDA | Croda International Plc | Outperform |
18
|
£47.46 | £65.12 | 7.46% | 6 | £6.43B |
| BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$279.83 | $536.80 | 51.88% | 1 | $7.74B |
| WCH | Wacker Chemie | Outperform |
17
|
102.25€ | 145.36€ | 22.25% | 9 | 5.00€B |
| CLN | Clariant | Outperform |
18
|
CHF13.89 | CHF16.11 | 7.99% | 6 | CHF4.53B |
| BIOCON | Biocon | Hold |
14
|
Rp305.20 | Rp270.86 | -13.17% | 14 | Rp356.47B |
| TNE | Technology One | Hold |
16
|
$16.12 | $16.29 | 2.05% | 12 | $5.29B |
| ALRM | Alarm.com Holdings | Outperform |
16
|
$68.27 | $67.13 | 21.58% | 7 | $3.34B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$12.00 | HK$3.96 | -68.00% | 0 | HK$24.72B |
| AZTA | Azenta | Hold |
16
|
$53.42 | $58.50 | 19.81% | 5 | $2.93B |
| QDEL | Quidel Corp | Hold |
16
|
$42.50 | $121.00 | 17.65% | 6 | $2.84B |
| TWST | Twist Bioscience | Outperform |
4
|
$41.21 | $34.00 | 6.77% | 2 | $2.40B |
| GH | Guardant Health | Buy |
6
|
$18.88 | $43.00 | 133.05% | 2 | $2.30B |
| PENN | PENN Entertainment | Outperform |
13
|
$15.13 | $29.89 | 45.41% | 1 | $2.29B |
| 300676 | BGI Genomics | - |
17
|
¥41.13 | ¥0.00 | -100.00% | 0 | ¥15.61B |
| NEO | NeoGenomics | Outperform |
8
|
$15.30 | $20.09 | 24.18% | 9 | $1.95B |
| MYGN | Myriad Genetics | Hold |
6
|
$19.47 | $22.08 | 28.40% | 8 | $1.77B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
| LAB | Standard BioTools | Buy |
11
|
$2.51 | $4.00 | 39.44% | 1 | $948.50M |
| 000710 | Berry Genomics Co.,Ltd | - |
10
|
¥7.23 | ¥56.76 | -100.00% | 0 | ¥5.09B |
| QTRX | Quanterix | Outperform |
11
|
$17.02 | $32.00 | 88.01% | 0 | $650.97M |
| FLGT | Fulgent Genetics | Hold |
16
|
$21.50 | $31.50 | 16.28% | 2 | $642.86M |
| CEVI | CellaVision AB (publ) | Outperform |
16
|
kr226.50 | kr191.75 | 8.17% | 3 | kr5.38B |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$1.83 | $12.67 | 91.26% | 4 | $449.37M |
| ADPT | Adaptive Biotechnologies | Outperform |
6
|
$3.01 | $8.67 | 99.34% | 2 | $386.11M |
| MACAY | Macay Holdings | - |
16
|
Php8.49 | Php0.00 | -100.00% | 0 | Php9.07B |
| GLAXO | GlaxoSmithKline Pakistan | - |
18
|
₨79.00 | ₨0.00 | -100.00% | 0 | ₨37.46B |
| PSNL | Personalis | Outperform |
6
|
$1.54 | $4.45 | 159.74% | 3 | $71.59M |
| IMMNOV | Immunovia AB (publ) | - |
0
|
kr1.94 | kr0.00 | -100.00% | 0 | kr747.75M |
| HEALTH | Nightingale Health Oyj | Outperform |
2
|
1.77€ | 1.10€ | -29.38% | 1 | 61.31€M |
| AGL | ANGLE | Buy |
8
|
£0.18 | £0.97 | 283.33% | 0 | £35.81M |
| BNGO | Bionano Genomics | Outperform |
6
|
$0.95 | $12.33 | 531.58% | 2 | $44.28M |
| TTOO | T2 Biosystems | Hold |
6
|
$3.72 | $8.68 | -19.35% | 0 | $24.09M |
| CNTG | Centogene N.V. | Outperform |
8
|
$0.44 | $1.37 | 213.64% | 0 | $23.96M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$0.92 | $5.00 | -100.00% | 1 | $21.49M |
| FRES | Fresh2 Group | - |
0
|
$0.39 | $0.00 | -100.00% | 0 | $20.50M |
| PRPO | Precipio | - |
0
|
$5.80 | $19.00 | -100.00% | 1 | $9.44M |
| NSTG | NanoString Technologies | - |
7
|
$0.21 | $5.02 | -100.00% | 4 | $8.52M |
| OPGN | OpGen |
2
|
$0.47 | $3.00 | -100.00% | 1 | $4.61M | |
| NVTA | Invitae | - |
4
|
$0.00 | $0.71 | 0.00% | 8 | $3.18M |
| ECX | Epigenomics | Buy |
6
|
1.62€ | 52.65€ | 940.12% | 1 | 1.57€M |
| BIOC.Q | Biocept | Hold |
-16
|
$0.00 | $8.00 | 0.00% | 0 | $0.13M |
| ARYC | Arrayit | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.11M |
| HTGM.Q | HTG Molecular Diagnostics | - |
6
|
$0.00 | $6.00 | 0.00% | 1 | $0.00M |